baber/WOPTO huggingface dataset:
Patent EA-004675-B1 (EA)
Title: METHOD FOR PREPARING SUBSTITUTED [1,4]DIAZEPINO[6,7,1-hi]INDOL-4-ONES
Inventor: BERNARDELLI PATRICK
IPC: C07D471/00
Filed: 2000-06-29
Abstract: 1. Process for the preparation of diazepino-indolone of formula in which: - A is hydrogen, C1-C4 alkyl, C1-C4 alkoxy, nitro, cyano or NH2; - B is C1-C4 alkyl; - Z is CH, then Z<1> and Z<2> are together CH or N; or - Z is N, then Z<1> and Z<2> are CH; - X<1> and X<2> are independently hydrogen or -C(=O)R4, R<5> is hydrogen or C1-C4 alkyl, salts, solvates thereof which are pharmaceutically acceptable, which comprises the intramolecular cyclization of a product of formula at a temperature not higher than 40 degree C in which A, Z, Z<1>, Z<2>, B, X<1> and X<2> have the meaning defined above and R is C1-C4 alkyl, in the presence of a weak Lewis acid catalyst selected from scandium trifluoromethanesulphonate; aluminium trifluoromethanesulphonate; lanthanide, silicon, magnesium, tin (II), copper (II), zinc or silver trifluoromethanesulphonates; dimethoxydicyclopentadienyltitanium (IV); dicyclopentadienyltitanium (IV) bis(trifluoromethanesulphonate); iron (III), aluminium or zinc acetylacetonate; zinc diacetate; dimethoxymagnesium; triisopropoxyaluminium; tetrabutoxytitanium (IV); tetraisopropoxytitanium (IV); trimethylboron; triethylaluminium; diethylzinc; triisobutylaluminium; tetrabutyltin (IV); triphenylboron; triphenylantimony; or boron, zinc, tin (II), antimony, titanium, scandium, indium, gallium or mercury (II) halides. 2. Process according to Claim 1, in which the said weak Lewis acid is scandium trifluoromethanesulphonate or zinc chloride. 3. Process according to Claim 1, in which the said weak Lewis acid is scandium trifluoromethanesulphonate. 4. Process according to Claim 1, characterized in that it comprises an additional stage in which a product (I), in which A is -NO2, is reduced to a product (I), in which A is -NH2. 5. Process according to Claim 1, in which A is -NH2, B is CH3, and X<1> and X<2> are independently hydrogen or -C(=O)OR<5>.
Patent EA-006841-B1 (EA)
Title: Transponder and transponder system
Inventor: VAVIK GEIR MONSEN
IPC: G06K19/07
Filed: 2001-03-01
Abstract: In a transponder (19) for amplification of a received signal (60) into an antenna (1), to a signal (61) for retransmission, and where the retransmitted signal (61) possibly may have information superimposed, a quenched oscillator (5) is incorporated as amplifying element. The oscillator (5) is preferably of superregenerative type and exhibits negative resistance (30) for the received signal (60). Transponders according to the present invention may be introduced as system elements in a wireless or wire based network to work as intelligent or unintelligent connections in the network. The transponders can also be used in positioning systems.
Patent EA-006173-B1 (EA)
Title: Absorbent embossed paper sheet, embossing cylinder, and method for the production thereof
Inventor: GRAFF PIERRE
IPC: B31F1/07
Filed: 2003-01-24
Abstract: Disclosed is a cotton cellulose sheet comprising at least one first embossed area (A1, A2) with protrusions on one side and corresponding indentations on the other side. The indentations have an essentially polygon-shaped base. The inventive sheet comprises at least one second non-embossed area (B). According to the invention: - the indentations 101', 102' are arranged at least according to one alignment; - the sides facing two adjacent indentations define a bridge (P) with straight or substantially straight edges having a length L which is greater than the greatest width D thereof. One or several interlinked bridges define a path between preferably two second non-embossed areas (B) which are separated by at least one embossed area (A1, A2). The invention also relates to a cylinder for embossing such a sheet.
Patent EA-009463-B1 (EA)
Title: Use of erythropoetin
Inventor: BAHLMANN FERDINAND HERMANN
IPC: A61P9/00
Filed: 2003-07-25
Abstract: The invention relates to the use of erythropoietin for the production of pharmaceutical compositions for the treatment of chronic acute renal failure and wound healing.
Patent EA-010339-B1 (EA)
Title: Low voltage power cable with polyolefin-based insulation layer
Inventor: JUNGKVIST JONAS
IPC: H01B3/44
Filed: 2004-10-22
Abstract: The present invention relates to a low voltage power cable comprising an insulation layer with a density below 1100 kg/mwhich comprises a polyolefin comprising 0.02 to 4 mol. % of a compound having polar groups and further comprises a compound having hydrolysable silane groups and include 0.0001 to 3 wt.-% of a silanol condensation catalyst. Furthermore, the present invention relates to a process for the production of said low voltage power cable and to the use of a polyolefin comprising 0.02 to 4 mol. % of a compound having polar groups in the production of an insulation layer for a low voltage power cable.
Patent EA-016880-B1 (EA)
Title: Regulatory nucleic acid elements
Inventor: ENENKEL BARBARA
IPC: C12N15/67
Filed: 2007-06-15
Abstract: The invention relates to DNS-sequences, particularly transcription- or expression increasing elements (TE-elements) and the use thereof on an expression vector in connection with an enhancer, a promoter, a product gene and a selection marker. The invention describes the SEQ ID NO: 1 and the TE-elements TE-01, -02, -03, -04, - 06, -07, -08, -10, -11 or -12. Due to their small size TE-06, TE-07 or TE-08 are particularly preferred. The sequence No. 1 is from a sequence region being upstream of the code region of the Ub/S27a-genes of CHO-cells. TE-elements cause an expression increase of the product gene with stable integration into the eukaryotic genome, preferably the CHO-DG44-genome. Chromosomal position effects are thus overcome, shielded or eliminated. Thus, the content of high producers of a transfection deposit and also the absolute expression level is increased up to fifteen fold.
Patent EA-015305-B1 (EA)
Title: Method for controlling mining conveyor system and system
Inventor: BELOGLAZOV NIKOLAJ EVGENIEVICH
IPC: B65G43/08
Filed: 2009-05-15
Abstract: The invention relates to automatin means of conveyor assemblies for use in mining, chemical and other industrial industries. The invention is aimed at increasing reliability and optimization of flow rate in operation of a complex conveyor transport facilities. The assigned inventive task is achieved by obtaining additional information concerning the location, state and rate of mechanism movement for periodic and long-lasting goods delivery to branching conveyors, calculate linear load based on said data at portions of traction units of said conveyors, determine the most loaded portions of the traction units of main conveyors and change the rate of traction units and cyclicity of mechanism's operation of periodic and long-lasting goods delivery for use of branching conveyors and transfer their operation to portions of traction units of the main conveyors having minimum linear load.
Patent EA-014492-B1 (EA)
Title: A method of presterilizing an aseptic tank and connecting conduits
Inventor: RINGSTROM ROLAND
IPC: A23C7/02
Filed: 2008-02-04
Abstract: The invention relates to a method of presterilizing an aseptic tank (1) and connecting conduits (8, 10, 11, 13, 14, 16). A certain amount of cold water is pumped into the tank (1) and the conduits (8, 10, 11, 13, 14, 16) and is caused to pass through a heat exchanger (6). In the heat exchanger, the water is heated to 120-150 C, whereafter the water is pumped across the tank (1) and conduits (8, 10, 11, 13, 14, 16) during 10-20 minutes.
Patent EA-019995-B1 (EA)
Title: Rosuvastatin salt, process for the preparation thereof and process for the preparation of pharmaceutically acceptable rosuvastatin salt
Inventor: BENKIC PRIMOZ
IPC: C07D239/42
Filed: 2010-01-14
Abstract: The invention relates to a salt of formula VIIwhere A isand Z is an amine of formula Zwhere R, Rand Rare independently selected from H, halogen, (C-C)alkyl, (C-C)alkoxy, CHF, CHFand CF, where halogen is independently selected from F, Cl, Br and I, and also to a process for preparing the same and to a process for preparing pharmaceutically acceptable rosuvastatin salt.
Patent EA-019279-B1 (EA)
Title: Method for purifying lithium bicarbonate
Inventor: TIIHONEN MARIKA
IPC: B01D15/36
Filed: 2010-03-01
Abstract: The invention relates to a method for purifying impure lithium bicarbonate by means of a cation exchange resin. In addition to solution purification by ion exchange, the treatment stages include the regeneration of impurity metals bound to the resin. Regeneration consists of washing the resin with water, elution with acid solution, washing with water, neutralisation with alkali solution and washing with water. It is characteristic of the method that neutralisation is performed with sodium hydroxide solution.
Patent EA-023601-B1 (EA)
Title: Method for measuring rock wettability
Inventor: CHEN QUAN
IPC: G01V3/32
Filed: 2010-11-19
Abstract: A method of comparing a secondary oil recovery process with a tertiary oil recovery process, the secondary oil recovery process and the tertiary oil recovery process being applied to a substantially fluid-saturated porous medium containing an oil phase and an aqueous phase, the method comprising using relaxation time measurements in the calculation of a wettability index modification factor for the oil phase or the aqueous phase, thereby comparing the tertiary oil recovery process with the secondary oil recovery process.
Patent EA-031699-B1 (EA)
Title: Packaging for a window and method for packing a window
Inventor: JOERGENSEN CHRISTIAN TAULOV
IPC: B65D85/48
Filed: 2012-10-04
Abstract: A packaging for a window comprising a folded sheet member and at least one fastener or bonder for interconnecting different sections of the sheet member for the formation of a box, where two lid sections are each connected to a side section of the sheet member. The sum of the widths of the lid sections is substantially equal to the width of a receiving section intended for carrying the window. The lid sections have different widths. The width of each lid section corresponds to at least 1/4 of the width of the receiving section. Preferably, the packaging comprises an indication that it should be opened at the joint between the two lid sections and one of the lid sections preferably has a standard width regardless of the size of the packaging (preferably approximately 40 cm). A packed window and a method for packing a window is also part of the invention.
Patent EA-029560-B1 (EA)
Title: Use of chimeric blood coagulation factor for reducing inhibitory immune response in a subject
Inventor: JIANG HAIYAN
IPC: C12P21/04
Filed: 2013-01-12
Abstract: The present invention provides the use of chimeric blood coagulation factor, in particular, Factor VIII (FVIII) polypeptides comprising a FVIII portion and an Fc portion for producing a medicament for reducing an inhibitory immune response in a subject at risk of developing inhibitory immune reactions, including anti-FVIII antibodies and/or cell-mediated immunity. The administration of such polypeptides is sufficient to promote coagulation and to induce immune tolerance to said blood coagulation factor. Such chimeric polypeptide can comprise full-length FVIII or a FVIII polypeptide containing a deletion, e.g., a full or partial deletion of the B domain. Also provided is a kit comprising a pharmaceutical composition comprising said chimeric blood coagulation factor.
Patent EA-027925-B1 (EA)
Title: Enediyne compounds, conjugates thereof, and methods for making and using the same
Inventor: CHOWDARI NAIDU S
IPC: C07D491/08
Filed: 2013-02-08
Abstract: The group of inventions relates to enediyne compounds having a structure represented by formula (IIa), (IIb), (IIc), (IId), (IIe), (IIf), (IIg), or (IIh)or a pharmaceutically acceptable salt thereof. These compounds can be used in chemotherapeutic drugs, especially in conjugates, for the treatment of diseases such as cancer.
Patent EA-024392-B1 (EA)
Title: Phenoxyethyl piperidine compounds
Inventor: SCHIFFLER MATTHEW ALLEN
IPC: C07D211/60
Filed: 2013-06-20
Abstract: The present invention provides a compound of the Formula IIwherein X isRis H, -CN, or F; Ris H or methyl; Ris H; and Ris H, methyl, or ethyl; or Rand Rjoined together form a cyclopropyl ring; or a pharmaceutically acceptable salt thereof.
Patent EA-028235-B1 (EA)
Title: Method and device by which aqueous polymer-containing biocides are atomized by means of ultrasound technology into a room
Inventor: RAUCHENSCHWANDTNER HARALD
IPC: B05B17/06
Filed: 2013-12-11
Abstract: The invention relates to a method and a device by which aqueous polymer-containing biocides are discharged, in the form of mist with a mean particle size of less than 10 μm, into a room by means of the ultrasound technology for disinfection of the room. The technical result of the invention consists in feeding an aqueous polymer-containing biocides to a room, in the form of mist with a mean particle size of less than 10 μm, in an unobtrusive and energy-saving manner, the method being implemented using a device convenient in transportation. Said technical result is attained by first atomizing a biocide using at least one ultrasound membrane that vibrates just several centimetres below the surface of fluid, after which the atomized aqueous polymer-containing biocide is discharged into the room using air as a carrier medium.
Patent EA-029324-B1 (EA)
Title: Electrode for oxygen evolution in industrial electrochemical processes
Inventor: CALDERARA ALICE
IPC: C25D17/10
Filed: 2013-11-29
Abstract: The invention relates to an electrode for electrolytic processes, in particular to an anode suitable for oxygen evolution comprising a valve metal substrate, a catalytic layer, a protection layer consisting of oxides of valve metals interposed between the substrate and the catalytic layer and an outer coating of oxides of valve metals. The electrode of the invention is particularly suitable for processes of cathodic electrodeposition of chromium from an aqueous solution containing Cr (III).
Patent EA-026437-B1 (EA)
Title: N-(3-((4-acylpiperazin-1-yl)methyl)phenyl)amides as modulators of the retinoid-related orphan receptor gamma (ror-gamma) and use thereof in the treatment of multiple sclerosis and psoriasis
Inventor: HAN FANGBIN
IPC: C07D407/12
Filed: 2013-12-05
Abstract: The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.
Patent EA-030423-B1 (EA)
Title: Apparatus for thermal treatment of an inner surface of a tubular or other enclosed structure
Inventor: BUMBULOVIC MLADEN
IPC: H05B7/18
Filed: 2014-05-26
Abstract: A heat treatment apparatus for heat treating an interior surface of a longitudinally extending cavity of a target structure. The apparatus has a processing head which comprises a longitudinally extending central support member and distal and proximal end caps protruding laterally from the central support member. Each end cap has a plurality of apertures configured to respectively receive distal and proximal ends of elongated plasma arc lamps and position the plasma arc lamps to extend longitudinally along and laterally around the central support member such that radiation emitted collectively by the plasma arc lamps is directed generally radially outwards from the processing head. The processing head also comprises a coolant pathway having heat exchange zones in thermal communication with the plasma arc lamps and coolant supply and return conduits in fluid communication with the heat exchange zones.
Patent EA-033585-B1 (EA)
Title: Method for processing vegetable raw material brassica oleracea
Inventor: MISA-HARRIS JOANNA
IPC: A23L3/3454
Filed: 2014-11-18
Abstract: A method for processing a vegetable raw material Brassica oleracea comprising: i) a dicing and shredding step comprising subjecting the raw material to mechanical size reduction; ii) a softening step comprising heating or freezing the raw material for a pre-determined period; and iii) a chemical treatment step comprising bringing the softened vegetable product into contact with peroxide or superoxide.
Patent EA-027991-B1 (EA)
Title: Nootropic agent "pantocalcin" in liquid form
Inventor: KULKIN SERGEJ NIKOLAEVICH
IPC: A61P25/28
Filed: 2015-01-16
Abstract: The invention relates to a pharmaceutical agent exhibiting mixed nootropic properties with a broad range of activity, having an effect on a gamma-aminobutyric acid (GABA) system, and can be used in medicine, in psychoneurological practice and in the pharmaceutical industry. The technical result of the invention consists in increasing the content of an active substance in a liquid form of the preparation (up to 40%) by means of improving the organoleptic properties thereof, and by providing the ability to decrease the viscosity of the liquid form of the preparation by means of decreasing the content therein of substances which increase the viscosity thereof and by means of increasing the water content.
Patent EA-033859-B1 (EA)
Title: Substrate provided with a thin-film stack having thermal properties and a substoichiometric intermediate layer
Inventor: MERCADIER NICOLAS
IPC: E06B3/66
Filed: 2015-09-29
Abstract: The invention relates to a substrate (10) coated on one face (11) with a thin-film stack (14) having reflection properties in the infra red and/or in solar radiation comprising a single metallic functional layer (140), in particular based on silver or on a metal alloy containing silver, and two antireflection coatings (120, 160), said coatings each comprising at least one dielectric layer (122, 164), said functional layer (140) being positioned between the two antireflection coatings (120, 160), characterized in that at least one of said antireflection coatings (120, 160) comprises an intermediate layer comprising a zinc tin oxide SnZnOwith a ratio of 0.1≤x/y≤2.4, with 0.75(2x+y)≤z≤0.95(2x+y) and having a physical thickness of between 2 and 25 nm, or even between 2 and 12 nm.
Patent EA-036490-B1 (EA)
Title: Antibodies binding to tfpi and composition comprising the same
Inventor: KIM DONG-SIK
IPC: A61P7/04
Filed: 2015-12-29
Abstract: The invention relates to antibodies that bind specifically to a tissue factor pathway inhibitor (TFPI), polynucleotides encoding these antibodies, vectors comprising said polynucleotides, host cells transformed with said vectors, a method for producing said antibodies, and a pharmaceutical composition for treating hemophilia, which comprises said antibodies as an active ingredient. The antibodies of the invention that bind specifically to TFPI can activate the extrinsic pathway of blood coagulation by inhibiting TFPI. Thus, the antibodies of the invention can be effectively used for the treatment of antibody-induced hemophilia patients and for the prevention of blood coagulation disease in hemophilia-A or hemophilia-B patients.
Patent EA-032697-B1 (EA)
Title: Amidoheteroaryl aroyl hydrazide ethynes
Inventor: CHOKSHI HEMANT ASHVINBHAI
IPC: C07D401/12
Filed: 2016-05-18
Abstract: The present invention relates to amidoheteroaryl aroyl hydrazide ethynes as tyrosine kinase inhibitors, a process of preparation thereof and the use of these compounds for the preparation of pharmaceutical compositions in the therapeutic treatment of disorders related to tyrosine kinases in humans.
Patent EA-036239-B1 (EA)
Title: Centrifugal pump impeller
Inventor: NIFANTOV YURY ALEXANDROVICH
IPC: F04D29/24
Filed: 2018-05-03
Abstract: The invention relates to the field of devices intended for pumping liquids and can be used in industry, agriculture and for domestic needs. The technical result achieved by the invention is to increase the generated pressure while maintaining the efficiency of a centrifugal pump impeller. The essence of the invention consists in that the centrifugal pump impeller is characterised in that the size of the outlet angle of a blade is in the range from 85 to 90°, and the shape of the blades is described by second-order surfaces, which permits the blades to be inclined towards the impeller rotation direction and stretched towards the inlet of the impeller.
Patent EA-039740-B1 (EA)
Title: Method for reduction of formaldehyde emissions from ester curable foundry binders used in forming foundry molds and cores (embodiments)
Inventor: TRIKHA SUDHIR K
Filed: 2016-06-10
Abstract: The invention relates to compositions and methods for reduction of formaldehyde odor and emission during the production and curing of molds and cores, particularly those cores and molds of the foundry industry which comprise ester curable phenolic binders. More specifically, included herein is an ester-curative comprising an ester and resorcinol which, when provided in a composition with a resin and an aggregate, effectively scavenges formaldehyde thereby reducing emission and odor of the same from the composition.
Patent EA-039668-B1 (EA)
Title: Absorbent article
Inventor: SAKAGUCHI SATORU
Filed: 2017-01-13
Abstract: This absorbent article (1) enables an enhanced fit to the body when wearing the article while limiting reductions to wear comfort and reductions to the absorption capacity of an absorbent body therein. The absorbent article (1) is provided with a front surface sheet (2), a back surface sheet (3), and an absorbent body (4) disposed within the front surface sheet and back surface sheet laminate. The absorbent article is further provided with a stretchable waist member (11) disposed within the laminate in a manner enabling stretching in the width direction W, and a pair of stretchable side members (7, 7) formed on the peripheral edge of the laminate in a manner enabling stretching in the width direction. One member and the other member of the pair of stretchable side members are formed, respectively, on one end and the other end of the laminate in the width direction. The stretchable waist member overlaps with each of the pair of stretchable side members in the lengthwise direction, is disposed further on the non-skin side than the absorbent body in the thickness direction, and overlaps with the absorbent body in the thickness direction but is not joined thereto.
Patent EA-037960-B1 (EA)
Title: Method of treatment of eosinophilic esophagitis using an anti-il-13 antibody
Inventor: TIMONY GREGG
IPC: A61K31/56
Filed: 2017-04-27
Abstract: The invention relates to a method of treating eosinophilic esophagitis (EoE), comprising administering to a subject in need of such treatment, an interleukin-13 (IL-13) antibody or an antigen binding fragment thereof.
Patent ES-2182627-B1 (ES)
Title: Procedimiento de fabricacion de unas mezclas reparadoras para instalaciones sanitarias de evacuacion y su aplicacion.
Inventor: ESTEBAN GARCIA LORENZO
IPC: E03F9/00
Filed: 2000-02-23
Granted: 2004-06-16
Abstract: Procedimiento de fabricación de unas mezclas para reparación de instalaciones sanitarias de evacuación y su aplicación. En la actualidad la reparación en el ámbito del hogar, comunitario o industrial, de material sanitario, bajantes generales de aguas pluviales, fecales, colectores, codos, en tuberías de PVC, hierro, fibrocemento o plomo, produce importantes paralizaciones y elevados costos y daños materiales. La solución evidente para estos problemas es contar con un procedimiento de reparación que sea a la vez duradero, rápido, económico y eficaz. Este procedimiento consiste en la fabricación de unas mezclas de resinas, endurecedores, polyester, fibra de vidrio y secantes, en un recipiente industrial de unas determinadas dimensiones y características, siendo posteriormente las masas aplicadas a la avería, hasta obtener su endurecimiento, y posterior lijado, para proceder por último a dar una capa de pintura al cloro caucho o con filtro solar dependiendo de la ubicación de la avería en elmaterial sanitario.